iHuman Inc. (IH) is a Beijing-based children's education technology company that sells subscription-based interactive learning apps and physical learning materials, primarily in mainland China. Its American depositary shares trade on the New York Stock Exchange. On Wednesday, the stock was quoted at $0.78, down 21.84% from the previous session's close of $1.00 — a decisive move lower. No verified corporate, regulatory, or analyst catalyst was identified for the drop, and the price action is consistent with the order-book fragility of a micro-cap that averages only a few thousand shares of daily turnover.
No verified news or fundamental catalyst found in company disclosures, wire reports, or analyst coverage explains Wednesday's decline. There was no earnings release, no SEC filing, no financing, and no rating change around the time of the move. The most plausible explanation is mechanical rather than fundamental.
Wednesday's quoted volume was approximately 1,000 shares — a fraction of the roughly 6,400-share three-month average and a small share of the float, which stands at about 14 million shares with insiders holding roughly 72% of the company. Quoted bid-ask spreads have recently run between roughly $0.44 and $1.27 for orders of only a few hundred shares, a spread wide enough that a single market order can reprice the tape by double digits. The decline is consistent with a thin order book and an isolated trade establishing a new low, rather than a reassessment of the company's value.
Wednesday's move is also in line with a stock that has repeatedly swung by double digits without news: shares rose 12.39% on Nov. 9 and then fell 19.69% the following session, both on modest volume. The stock is a habitual large mover, which makes today's percentage decline less informative than the headline suggests.
The larger trend is not in dispute. iHuman's second-quarter 2026 results, reported Sept. 29, showed revenue of RMB 173.4 million, down about 18% year over year, alongside a net loss as operating expenses rose. Management cited a persistently challenging operating environment. The company has also been active on acquisitions, having completed a deal for the businesses behind its All Knowledge and Perfect Lingo products earlier in 2026. That combination — contracting top line, thin profitability, and an ADR that has lost about 64% over twelve months — leaves little fundamental cushion under the shares and makes the equity prone to sharp, low-volume repricing.
Volume on Wednesday was well below normal rather than elevated, which argues against a conviction-driven institutional exit and points instead to a liquidity event in an illiquid name. The decline pushed the ADR below its previous 52-week low of $0.99 and further beneath its 50-day moving average near $1.15 and its 200-day average near $1.48 — a breakdown of the narrow $0.99–$1.27 range the stock has held since early November. The move was idiosyncratic: iHuman's beta is close to zero, its institutional ownership is minimal, and there is no sign the decline reflected a sector-wide or index-level event. For a security this thinly traded, technical levels are more descriptive than predictive, but the loss of the $1.00 handle is the clearest signal on the chart.
The score runs from 0, meaning no meaningful news and a price move entirely normal for the stock, to 100, meaning transformative news and an extreme, rare move. iHuman's score is 46 out of 100.
Verified news strength was essentially nil — no disclosure or development was found, so catalyst strength contributed almost nothing. The price move, however, was highly unusual for the stock's recent history: it was roughly 8.8 times the 2.5% average absolute daily change of the past 60 sessions, and a move of this size did not occur once in that window. Those two components combine to a mid-range score: an exceptional move without an identifiable cause.
The next scheduled catalyst is the company's third-quarter 2026 results, expected in late December. Investors will focus on whether revenue declines stabilize, whether operating expenses can be contained, and whether management returns to profitability. The company carries a large net cash position relative to its market capitalization and pays an annual dividend, both of which are worth monitoring given the share price's slide. There is no meaningful sell-side coverage or consensus estimate for the current fiscal year, which limits visibility. Key risks include continued demand weakness in Chinese children's education spending, currency translation effects on the RMB-denominated business, the widening gap between the quoted bid and ask, and the possibility that the shares remain range-bound without a clear fundamental trigger.
Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions make it into the curated Trending AI Robots section. The bots differ widely by strategy, holding timeframe, performance metrics, and the symbols they trade, so the lineup shifts as market conditions change. Reviewing the current leaders can help traders compare approaches and identify which automated strategies are working right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for IH crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IH as a result. In 97 of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for IH turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 46 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
IH moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The RSI Indicator entered the oversold zone -- be on the watch for IH's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
IH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.069) is normal, around the industry mean (1.158). P/E Ratio (2.511) is within average values for comparable stocks, (8.484). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.354) settles around the average of (4.151) among similar stocks. P/S Ratio (0.537) is also within normal values, averaging (27.566).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. IH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherConsumerSpecialties